Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

  • There is currently no data for POLX

Director dealing

2 Jan 2020 16:50

RNS Number : 6117Y
Polarean Imaging PLC
02 January 2020
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

Director Dealing

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 31 December 2019 that Mr Richard Hullihen, the Company's CEO, has purchased a total of 347,100 ordinary shares of £0.00037 ("Ordinary Shares") via three transactions which are summarised in the table below (the "Transactions").

Date of Transaction

Number of Ordinary Shares purchased

Price per Ordinary Share

13 December 2019

100,000

20.22p

16 December 2019

100,000

20.02p

27 December 2019

147,100

23.87p

 

Following this Transactions, Mr Hullihen holds a beneficial interest in 2,928,899 Ordinary Shares, representing 2.56 per cent. of the Company's issued share capital with voting rights.

 

Enquiries: 

 

Polarean Imaging plc 

www.polarean.com / www.polarean-ir.com 

Richard Hullihen, Chief Executive Officer 

Via Walbrook PR 

Richard Morgan, Chairman 

 

 

 

SP Angel Corporate Finance LLP 

Tel: +44 (0)20 3470 0470  

David Hignell / Soltan Tagiev (Corporate Finance) 

 

Vadim Alexandre / Rob Rees (Corporate Broking)

 

 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Mr Richard Hullihen

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Polarean Imaging Plc

b)

LEI:

213800DGR2BHXJ36OL37

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Ordinary shares of £0.00037

GB00BF3DT583

b)

Nature of the transaction:

Purchase of shares

c)

Price(s) and volume(s):

 

Transaction

Price(s)

Volume(s)

(i)

(ii)

(iii)

20.22 pence

20.02 pence

23.87 pence

100,000

100,000

147,100

 

d)

Aggregated information:

Aggregated volume:

Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

See above

347,100

 

 

 

e)

Date of the transactions:

(i): 13 December 2019

(ii): 16 December 2019

(iii): 27 December 2019

f)

Place of the transactions:

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZGGMVZNGGZM
Date   Source Headline
28th Jan 20227:00 amRNSTotal Voting Rights
4th Jan 20227:00 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSTotal Voting Rights
26th Oct 20214:41 pmRNSSecond Price Monitoring Extn
26th Oct 20214:36 pmRNSPrice Monitoring Extension
26th Oct 20212:05 pmRNSSecond Price Monitoring Extn
26th Oct 20212:00 pmRNSPrice Monitoring Extension
12th Oct 20214:41 pmRNSSecond Price Monitoring Extn
12th Oct 20214:35 pmRNSPrice Monitoring Extension
12th Oct 20212:06 pmRNSSecond Price Monitoring Extn
12th Oct 20212:00 pmRNSPrice Monitoring Extension
11th Oct 20219:05 amRNSSecond Price Monitoring Extn
11th Oct 20219:00 amRNSPrice Monitoring Extension
11th Oct 20217:00 amRNSSystem installation
11th Oct 20217:00 amRNSDirector dealings
6th Oct 20214:40 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:03 pmRNSComplete Response Letter received from FDA
24th Sep 20217:00 amRNSTransfer of warrants
3rd Sep 20217:00 amRNSHolding(s) in Company
2nd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSTotal Voting Rights
23rd Jul 20219:29 amRNSBlock listing application
13th Jul 20212:26 pmRNSResult of AGM
9th Jul 20217:00 amRNSGrant of Options & Director Compensation Reduction
7th Jul 20217:00 amRNSNew System Installation
4th Jun 20217:00 amRNSFinal Results
26th May 20217:00 amRNSArticle on hyperpolarised xenon
25th May 20217:00 amRNSConference attendance at Mello
17th May 20217:00 amRNSExercise of warrants
14th May 20219:30 amRNSConference attendances
10th May 20217:00 amRNSNew system order
4th May 202111:06 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
16th Apr 202110:01 amRNSExercise of warrants
6th Apr 20213:05 pmRNSResult of General Meeting
6th Apr 20217:00 amRNSResult of Open Offer
1st Apr 20214:52 pmRNSTotal Voting Rights
29th Mar 20217:00 amRNSInvestor presentation
25th Mar 20217:00 amRNSExercise of Warrants
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20215:36 pmRNSPublication of Circular and Notice of GM
16th Mar 20217:00 amRNSResult of Placing and Subscription, PDMR Dealings
15th Mar 20215:50 pmRNSProposed Placing, Subscription and Open Offer
24th Feb 20217:00 amRNSExercise of Warrants
22nd Feb 20217:00 amRNSBoard appointment
25th Jan 20217:00 amRNSChange of Nominated Adviser
8th Jan 20212:05 pmRNSSecond Price Monitoring Extn
8th Jan 20212:01 pmRNSPrice Monitoring Extension
23rd Dec 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.